Pacemaker-related endocarditis: clinical features and treatment.
OBJECTIVE
Removal of the entire infected system is the traditionally indicated management of pacemaker lead endocarditis (PLE), based on expert recommendations. Herein is described the present authors' experience with this condition.


METHODS
Between 1987 and 2004, all consecutive patients with PLE treated at a tertiary referral university hospital and a community hospital were prospectively selected. Clinical features, management and outcome were analyzed.


RESULTS
Thirteen cases of PLE were diagnosed. Surgery was performed in 10 cases, and medical treatment alone in three (due to advanced age in two cases and because of terminal colon cancer in one case). Four subjects died before discharge: three deaths occurred after surgery (one patient died due to refractory ventricular arrhythmia and two from persistent sepsis), and one unoperated patient died from sepsis and severe renal failure. No deaths or late surgeries were observed after a mean follow up period of 37 +/- 14 months. Both patients who survived hospitalization and underwent only medical treatment were free from late complications after 30 and 60 months follow up, respectively.


CONCLUSIONS
Some patients with PLE present a good evolution without surgery, suggesting that surgical treatment is not mandatory in this situation. However, an indication for surgery may be similar to that for other cases of infective endocarditis.
Ruiz
Martín
M
Cardiology Service, Hospital Reina Sofía, Córdoba, Spain. mruor@supercable.es
Anguita
Manuel
M
Castillo
Juan C
JC
Delgado
Mónica
M
Romo
Elías
E
Torres
Francisco
F
Mesa
Dolores
D
Franco
Manuel
M
Vallés
Federico
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020878:Device Removal; D019468:Disease Management; D004697:Endocarditis, Bacterial / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D016984:Enterococcus faecium; D005260:Female; D005500:Follow-Up Studies; D016908:Gram-Positive Bacterial Infections / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D011446:Prospective Studies; D013211:Staphylococcus aureus; D013212:Staphylococcus epidermidis; D016019:Survival Analysis; D013997:Time Factors; D017211:Treatment Failure